Kestra Advisory Services’s Plus Therapeutics PSTV Stock Holding History

Kestra Advisory Services’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,032	Closed	-$4.2K	–	3349
2026 Q1	$4.2K	Hold	1,032	–	–	﹤0.01%	3110
2025 Q4	$13.2K	Hold	1,032	–	–	﹤0.01%	4531
2025 Q3	$17.6K	Buy	+1,032	New	+$12.7K	﹤0.01%	2885

Other funds holding PSTV

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Kestra Advisory Services's PSTV Position: Q2 2026 in Review

Kestra Advisory Services sold out of Plus Therapeutics (PSTV) in Q2 2026, closing a stake of 1,032 shares — an estimated $4.2K sold.

Kestra Advisory Services first reported a position in PSTV in Q3 2025 and held it in 3 quarters. The position peaked at $17.6K in Q3 2025. 4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

Kestra Advisory Services reported no remaining Plus Therapeutics position as of Q2 2026 after selling out during the quarter.
Kestra Advisory Services sold 1,032 Plus Therapeutics shares in Q2 2026, an estimated $4.2K.
Kestra Advisory Services first reported a position in Plus Therapeutics in Q3 2025 and held it in 3 quarters.
Kestra Advisory Services's Plus Therapeutics position peaked at $17.6K in Q3 2025.
4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.